Vision screening for correctable visual acuity deficits in school-age children and adolescents
Editorial Group: Cochrane Eyes and Vision Group
Published Online: 18 OCT 2004
Assessed as up-to-date: 3 APR 2006
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Powell C, Wedner S, Hatt SR. Vision screening for correctable visual acuity deficits in school-age children and adolescents. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD005023. DOI: 10.1002/14651858.CD005023.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 18 OCT 2004
Although the benefits of vision screening seem intuitive the value of such programmes in junior and senior schools has been questioned. In addition to this, there exists a lack of clarity regarding the optimum age for screening and frequency at which to carry out screening.
The objective of this review was to evaluate the effectiveness of vision screening programmes carried out in schools in reducing the prevalence of undetected, correctable visual acuity deficits due to refractive error in school-age children.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), which contains the Cochrane Eyes and Vision Trials Register, in The Cochrane Library (2006, Issue 1), MEDLINE (1966 to March 2006) and EMBASE (1980 to March 2006). No language or date restrictions were placed on these searches.
We planned to include randomised controlled trials, including randomised cluster controlled trials.
Data collection and analysis
Two review authors independently assessed study abstracts identified by the electronic searches. No trials were identified that met the inclusion criteria.
As no trials were identified, no formal analysis was performed. A narrative synthesis of other retrieved studies was undertaken in order to explain current practice.
At present there are no robust trials available that allow the benefits of school vision screening to be measured. The disadvantage of attending school with a visual acuity deficit also needs to be quantified. The impact of a screening programme will depend on the geographical and socio-economic setting in which it is conducted. There is, therefore, clearly a need for well-planned randomised controlled trials to be undertaken in various settings so that the potential benefits and harms of vision screening can be measured.
Plain language summary
Screening school aged children and adolescents for reduced vision caused by the need for glasses
Worldwide, the leading cause of reduced vision in children is an unidentified need for them to wear glasses. The reduced vision that results from abnormal focusing (refractive error) can cause the children to screw up their eyes and complain of headaches. Reduced vision may affect academic performance, choice of occupation and socio-economic status in adult life. Genetic and environmental factors are known to affect the development of refractive error; it is also more common in certain racial groups. Short sightedness has become the commonest eye condition. The need to correct refractive error is determined by its effect on vision. Normal vision can usually be restored by wearing corrective glasses or contact lenses. However, there is some evidence that correction may cause an error to persist where it might otherwise have resolved or reduced naturally. Vision screening is used widely but is concentrated in developed countries; in developing countries it may serve the purpose of providing access to health care. The value of screening after school entry has been queried. Programmes vary with regard to testing personnel, set threshold for failure, frequency and setting. The disability caused by a vision deficit has not been quantified and the optimum age and number of occasions for screening have not been established. The aim of this review was to find studies that evaluated the effectiveness of school vision screening programmes in first identifying children with reduced vision. No eligible randomised studies were found. There is a clear need for reliable evidence to measure the effectiveness of vision screening. A narrative synthesis of other retrieved studies was undertaken in order to explain current practice.
我們檢索the Cochrane Central Register of Controlled Trials (CENTRAL)，其包含考科藍圖書館中的the Cochrane Eyes and Vision Trials Register(2006年，第1期)，MEDLINE (1966至2006年3月)與EMBASE (1980至2006年3月)。這些檢索策略沒有限制語言或日期。
此翻譯計畫由臺灣國家衛生研究院(National Health Research Institutes, Taiwan)統籌。